Continued here: Jounce Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Friday, November 6, 2020
Continued here: Jounce Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Friday, November 6, 2020
Visit link: Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders
Excerpt from: OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial for Hypertrophic Scars
Continue reading here:BioFlorida Names AIM ImmunoTech CEO Thomas K. Equels as Entrepreneur of the Year
Read more: Generex Subsidiary NuGenerex Immuno-Oncology Announces Appointment of Dr. Tamera Coyne-Beasley to the Scientific Advisory Board for its COVID-19...
Read this article: Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trials of Setmelanotide in The Lancet Diabetes & Endocrinology
Original post: CymaBay Therapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
See the rest here: Ocugen to Present at the GCFF Virtual Conference - Diversified Investing Strategies
Go here to see the original: Immutep to Collaborate with LabCorp to Develop Oncology Services and Products
Read the original:Sorrento Announces That Intranasal Administration of COVI-AMG™ Neutralizing Antibody Prevented COVID-19 Disease Progression in Infected Hamsters...
Recent Comments